120
Participants
Start Date
January 25, 2022
Primary Completion Date
August 7, 2024
Study Completion Date
December 25, 2024
Liuwei Dihuang Pill (marketed product in China)
LDP group and placebo group were used for treatment. The random number is generated by the central randomization system. All the recruiters were divided into placebo group and LDP group. The numbers will be assigned according to random numbers. In this study, qualified subjects were randomly assigned to the LDP group and placebo group at a ratio of 1:1. The drug was administered for 48 weeks, 3 times a day, 8 pills each time.
Liuwei Dihuang Pill（placebo ）
LDP group and placebo group were used for treatment. The random number is generated by the central randomization system. All the recruiters were divided into placebo group and LDP group. The numbers will be assigned according to random numbers. In this study, qualified subjects were randomly assigned to the LDP group and placebo group at a ratio of 1:1. The drug was administered for 48 weeks, 3 times a day, 8 pills each time.
Community Health Service Center of North Sichuan Road, Hongkou District, Shanghai, Shanghai
Jiaxing Street Community Health Service Center, Hongkou District, Shanghai, Shanghai
Community Health Service Center of Tianlin Street, Xuhui District, Shanghai, Shanghai
Sixth people's Hospital Affiliated to Shanghai Jiaotong University, Shanghai
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai
Juquan New Town Community Health Service Center, Gucun Town, Baoshan District, Shanghai, Shanghai
Shanghai University of Traditional Chinese Medicine
OTHER
Shanghai Jiao Tong University School of Medicine
OTHER